Point72 Asset Management, L.P. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$8,566,353
+6683.7%
335,278
+7514.8%
0.02%
Q2 2023$126,278
-93.4%
4,403
-94.5%
0.00%
-100.0%
Q1 2023$1,926,900
+76.1%
80,388
+24.6%
0.01%
+50.0%
Q4 2022$1,093,920
-88.0%
64,500
-89.5%
0.00%
-89.2%
Q3 2022$9,146,000
-36.4%
617,124
-32.4%
0.04%
-39.3%
Q2 2022$14,376,000
+25.4%
913,323
+114.8%
0.06%
+32.6%
Q1 2022$11,463,000
+10.0%
425,200
+90.7%
0.05%
-32.4%
Q2 2020$10,424,000223,0130.07%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders